Novel CAR T-Cell Therapies May Improve Outcomes Vs SOCs in Multiple Myeloma
Barry Paul, MD, listed cilta-cel, anito-cel, and arlo-cel as 3 of the CAR T-cell therapies with the most promising efficacy in patients with multiple myeloma.